Lb Pharmaceuticals Inc (LBRX)

CIK 1691082 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lb Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Sep 3, 2026424B30001193125-26-381100
Sep 3, 20268-K0001193125-26-381076
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352336
Aug 11, 20268-K0001193125-26-343479
Aug 11, 2026424B30001193125-26-343542
Aug 11, 202610-Q0001193125-26-343490
Aug 3, 202640001193125-26-331058
Jul 29, 2026424B30001193125-26-322276
Jul 29, 20268-K0001193125-26-322208
Jul 29, 2026SCHEDULE 13G/A0002012383-26-002809
Jul 22, 20268-K0001193125-26-311357
Jul 22, 2026424B30001193125-26-311394
Jul 16, 2026SCHEDULE 13G0000019617-26-000264
Jun 10, 2026424B30001193125-26-266020
Jun 10, 20268-K0001193125-26-265867
Jun 9, 20261440001972481-26-000189
Jun 9, 20268-K0001193125-26-263724
Jun 9, 2026424B30001193125-26-263737
Jun 5, 202640001609805-26-000003
Jun 5, 202640001992908-26-000011
Jun 5, 202640001813937-26-000003
Jun 5, 202640002031342-26-000002
Jun 5, 202640001533228-26-000006
Jun 5, 202640001187308-26-000002
Jun 5, 202640001771213-26-000002